In today’s briefing:
- MSCI May 2022 Index Rebalance: Flow Due to FIF Changes
- Sihuan Pharma (460 HK) Denies China Resources Approach
- Chinese Property Weekly – 13 May 2022 – Lucror Analytics
- Chinese Property Weekly – 13 May 2022 – Lucror Analytics
- Polen Global Emerging Markets Growth Q1 2022 Portfolio Manager Commentary
- Weekly Wrap – 13 May 2022
- Weekly Wrap – 13 May 2022
MSCI May 2022 Index Rebalance: Flow Due to FIF Changes
- There are quite a lot of stocks that have changes to their Foreign Inclusion Factor (FIF) at the May SAIR since MSCI comprehensively assesses the float for stocks.
- The largest passive inflows will be on Tencent, Kuaishou Technology, JD Health, Macquarie Group, Shin Etsu Chemical, Recruit Holdings, Olympus Corp, Naver Corp and Sun Hung Kai Properties.
- Changes to FIFs are tougher to forecast and not very widely tracked, so pre-positions are likely to be lower and the stocks with higher ADV to buy/sell should outperform/underperform.
Sihuan Pharma (460 HK) Denies China Resources Approach
- Sihuan Pharmaceutical (460 HK) has shot down rumours that it is under negotiation with potential investors in respect of privatisation.
- Reportedly SOE China Resources is in talks with Sihuan Pharma’s chairman in a deal valuing the company at US$3bn or a 114% premium to the current price.
- The logic of a privatisation makes sense. I would not be so quick to dismiss the denial. Plus Sihuan Pharma is very cash-rich.
Chinese Property Weekly – 13 May 2022 – Lucror Analytics
The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.
Chinese Property Weekly – 13 May 2022 – Lucror Analytics
The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.
Polen Global Emerging Markets Growth Q1 2022 Portfolio Manager Commentary
- Polen Capital is a high-conviction growth investment manager.
- Over the first quarter of 2022, the Polen Global Emerging Markets Growth Composite Portfolio returned -14.68% gross and – 14.96% net of fees.
- The top relative and absolute detractors over the quarter included Yandex N.V.
Weekly Wrap – 13 May 2022
Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.
In this Insight:
- China Jinmao Holdings
- Guangzhou R&F Properties
- Sunac China Holdings
- Greenland Hong Kong Holdings
- Evergrande
and more…
Weekly Wrap – 13 May 2022
Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.
In this Insight:
- China Jinmao Holdings
- Guangzhou R&F Properties
- Sunac China Holdings
- Greenland Hong Kong Holdings
- Evergrande
and more…
Before it’s here, it’s on Smartkarma